Multicenter study on the incidence of Guillain-Barre Syndrome during the COVID-19 pandemic

Multicenter study on the incidence of Guillain-Barre Syndrome during the COVID-19 pandemic - Multicenter study on the incidence of Guillain-Barre Syndrome during the COVID-19 pandemic

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045560

Enrollment

500

Registered

2021-10-01

Start date

2021-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Guillain-Barre Syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients newly diagnosed with GBS and hospitalized between January 2018 and July 2021

Exclusion criteria

Exclusion criteria: Patients transferred from another hospital

Design outcomes

Primary

Measure	Time frame
The changes of incidence of Guillain-Barre Syndrome	—

Secondary

Measure	Time frame
The relationship between the incidence of infectious enteritis and Guillain-Barre Syndrome	—

Countries

Japan

Contacts

Public ContactToshiyuki Hayashi

Nippon Medical School Neurology

toshi-h-06@nms.ac.jp+81-3-3822-2131

Outcome results